Header Logo
Last Name

Kenneth Wayne Jackson

TitleProf,Asoc of Research
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentWarren Medical Research Inst
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. DeVette CI, Andreatta M, Bardet W, Cate SJ, Jurtz VI, Jackson KW, Welm AL, Nielsen M, Hildebrand WH. NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors. Cancer Immunol Res. 2018 06; 6(6):636-644. PMID: 29615400.
      View in: PubMed
    2. McMurtrey C, Harriff MJ, Swarbrick GM, Duncan A, Cansler M, Null M, Bardet W, Jackson KW, Lewinsohn DA, Hildebrand W, Lewinsohn DM. T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells. PLoS One. 2017; 12(11):e0188288. PMID: 29176828.
      View in: PubMed
    3. Patterson AM, Kaabinejadian S, McMurtrey CP, Bardet W, Jackson KW, Zuna RE, Husain S, Adams GP, MacDonald G, Dillon RL, Ames H, Buchli R, Hawkins OE, Weidanz JA, Hildebrand WH. Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. Mol Cancer Ther. 2016 Feb; 15(2):313-22. PMID: 26719579; PMCID: PMC4747837 [Available on 02/01/17].
    4. Jackson KW, Christiansen VJ, Yadav VR, Silasi-Mansat R, Lupu F, Awasthi V, Zhang RR, McKee PA. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase. Neoplasia. 2015 Jan; 17(1):43-54. PMID: 25622898; PMCID: PMC4309729.
    5. Yaciuk JC, Skaley M, Bardet W, Schafer F, Mojsilovic D, Cate S, Stewart CJ, McMurtrey C, Jackson KW, Buchli R, Olvera A, CedeƱo S, Plana M, Mothe B, Brander C, West JT, Hildebrand WH. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells. J Virol. 2014 Nov; 88(22):12992-3004. PMID: 25165114; PMCID: PMC4249081.
    6. Kaabinejadian S, Piazza PA, McMurtrey CP, Vernon SR, Cate SJ, Bardet W, Schafer FB, Jackson KW, Campbell DM, Buchli R, Rinaldo CR, Hildebrand WH. Identification of class I HLA T cell control epitopes for West Nile virus. PLoS One. 2013; 8(6):e66298. PMID: 23762485; PMCID: PMC3677933.
    7. Christiansen VJ, Jackson KW, Lee KN, Downs TD, McKee PA. Targeting inhibition of fibroblast activation protein-a and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments. Neoplasia. 2013 Apr; 15(4):348-58. PMID: 23555181; PMCID: PMC3612908.
    8. Nguyen AT, Feasley CL, Jackson KW, Nitz TJ, Salzwedel K, Air GM, Sakalian M. The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles. Retrovirology. 2011 Dec 07; 8:101. PMID: 22151792; PMCID: PMC3267693.
    9. Lee KN, Jackson KW, Terzyan S, Christiansen VJ, McKee PA. Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design. Biochemistry. 2009 Jun 16; 48(23):5149-58. PMID: 19402713; PMCID: PMC4470291.
    10. Christiansen VJ, Jackson KW, Lee KN, McKee PA. The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity. Blood. 2007 Jun 15; 109(12):5286-92. PMID: 17317851; PMCID: PMC1890835.
    11. Christiansen VJ, Jackson KW, Lee KN, McKee PA. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV. Arch Biochem Biophys. 2007 Jan 15; 457(2):177-86. PMID: 17174263; PMCID: PMC1857293.
    12. Lee KN, Jackson KW, Christiansen VJ, Lee CS, Chun JG, McKee PA. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood. 2006 Feb 15; 107(4):1397-404. PMID: 16223769.
      View in: PubMed
    13. Hickman-Miller HD, Bardet W, Gilb A, Luis AD, Jackson KW, Watkins DI, Hildebrand WH. Rhesus macaque MHC class I molecules present HLA-B-like peptides. J Immunol. 2005 Jul 01; 175(1):367-75. PMID: 15972670.
      View in: PubMed
    14. Lee KN, Jackson KW, Christiansen VJ, Chung KH, McKee PA. Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal. Curr Med Chem Cardiovasc Hematol Agents. 2004 Oct; 2(4):303-10. PMID: 15320781.
      View in: PubMed
    15. Lee KN, Jackson KW, Christiansen VJ, Chung KH, McKee PA. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. Blood. 2004 May 15; 103(10):3783-8. PMID: 14751930.
      View in: PubMed
    16. Hickman HD, Luis AD, Bardet W, Buchli R, Battson CL, Shearer MH, Jackson KW, Kennedy RC, Hildebrand WH. Cutting edge: class I presentation of host peptides following HIV infection. J Immunol. 2003 Jul 01; 171(1):22-6. PMID: 12816978.
      View in: PubMed
    17. Lee KN, Jackson KW, McKee PA. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis. Thromb Res. 2002 Feb 01; 105(3):263-70. PMID: 11927133.
      View in: PubMed
    18. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002 Jan 10; 415(6868):175-9. PMID: 11805836.
      View in: PubMed
    Jackson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description